# Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial

> **NCT03358355** · PHASE1,PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 9 (actual)

## Conditions studied

- Peripheral Artery Disease
- PAD
- Peripheral Arterial Disease

## Interventions

- **DRUG:** unacelyated ghrelin

## Key facts

- **NCT ID:** NCT03358355
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-07
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358355, "Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03358355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*